RIL
COGT icon

Rothschild Investment LLC’s Cogent Biosciences COGT Stock Holding History

Rothschild Investment LLC’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
294
+8
+3% +$280 ﹤0.01% 1807
2026
Q1 		$11K Buy
286
+12
+4% +$443 ﹤0.01% 1646
2025
Q4 		$9.73K Buy
274
+14
+5% +$394 ﹤0.01% 1587
2025
Q3 		$3.73K Sell
260
-15
-5% -$178 ﹤0.01% 1843
2025
Q2 		$1.98K Buy
275
+120
+77% +$665 ﹤0.01% 2091
2025
Q1 		$928 Buy
155
+85
+121% +$666 ﹤0.01% 2386
2024
Q4 		$546 Sell
70
-50
-42% -$498 ﹤0.01% 2500
2024
Q3 		$1.3K Buy
120
+50
+71% +$487 ﹤0.01% 1974
2024
Q2 		$590 Buy
+70
New +$531 ﹤0.01% 1909

Other funds holding COGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Rothschild Investment LLC's COGT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Cogent Biosciences (COGT) stake by 2.8% in Q2 2026, buying an estimated $280 and bringing the position to 294 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Rothschild Investment LLC first reported a position in COGT in Q2 2024 and has held it in 9 quarters since. 93 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Rothschild Investment LLC held 294 shares of Cogent Biosciences worth $11.4K as of Q2 2026.
  • Rothschild Investment LLC bought 8 Cogent Biosciences shares in Q2 2026, an estimated $280.
  • Cogent Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1807 holding.
  • Rothschild Investment LLC first reported a position in Cogent Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 93 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.